van der Lans R, Otten JJ, Adriaensen GFJPM, Benoist LBL, et al. Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps. Rhinology 2024;62:383-384.
PMID: 38478151